placebo group 中文意思是什麼
placebo group
解釋
安慰劑組-
At end - point, the venlafaxine xr group had a significantly greater decrease in the number of days with headache compared with placebo ( p = 0. 05 )
治療結束時，與安慰劑比較，文拉法辛緩釋劑明顯減少了頭痛天數。 -
Methods : fifty - one systolic hf patients with left ventricular ejection fraction ( lvef ) < 40 % were randomly assigned to receive 1 - year treatment of candesartan and spironolactone ( combination group ) or candesartan and placebo ( control group )
方法： 51名左室射血分數（ lvef ） < 40 %的收縮性心力衰竭患者隨機分配到接受坎地沙坦和螺內酯治療1年（聯合治療組）或坎地沙坦和安慰劑治療（對照組） 。 -
The good news, the editorial writers say, is that women in the placebo group experienced about a 30 percent reduction in seerity and frequency of symptoms during the 12 - month follow - up period
好消息是，社論作者說，安慰劑試驗組的婦女在12個月的隨訪期間，頻繁和嚴重的癥狀減少了30 。 -
Results observation on local lesion showed that the scores of erythema, infiltration, scaly eruption, pruritus were significantly improved in difference between the cebo group and the daivonex group p001. but in the placebo control group, significant improvement was only shown in scaly eruption scores wtbxp001, so, the improvement in skin lesion in the placebo group was significantly inferior to that in the other two groups p001
結果局部癥狀改善情況：中藥組和西藥組紅斑鱗屑浸潤瘙癢程度治療前後評分比較，差異有顯著性wtbxp001 ，而安慰劑組僅鱗屑評分差異有顯著性p001治療后兩治療組與安慰劑組比較，差異均有顯著性p001 。 -
Methods adopting blockrandomized, open, positive western medicine and placebo parallel group controlled method, a total of 120 enrolled patients were administered orally with saoxuan pill, and randomized into three groups respectively treated with external application of cebo, daivonex, or vehicle control twice a day for 4 weeks. the changes of erythema, infiltration, scaly eruption, pruritus and the area of lesion were evaluated, the safety and the initiating time of symptom improvement itsi were observed as well
將120例入選患者在口服掃癬丸情況下，分別採用復方莪倍軟膏達力士軟膏軟膏基質外塗治療4周，療程結束后評價紅斑浸潤鱗屑瘙癢的改善情況及皮損面積改變情況及安全性，並觀察癥狀改善時間。 -
The itsi of pruritus was shorter in cebo group than that in the daivonex group and the placebo group p001, but that of other symptoms showed insignificant difference between the cebo group and the daivonex group, as for comparing in itsi of erythema, infiltration, scaly eruption and pruritus, it was significantly shorter in the cebo group and daivonex group than that in the placebo group respectively p001. the occurrence of adverse events in the cebo group had insignificant difference to that in the daivonex group, but the recurrence rate in the former was significantly lower than that in the latter p005
中藥組瘙癢癥狀改善時間少於西藥組及安慰劑組，差異有顯著性p001 ，而其他癥狀改善時間差異無顯著性中藥組及西藥組的紅斑鱗屑浸潤癥狀改善時間均少於安慰劑組，差異有顯著性p 001中藥組與西藥組不良事件發生比較差異無顯著性而中藥組復發相對少於西藥組。 -
Based on the conventional treatment with hypoglycemic agents, patients in the treated group were treated with ldsc plus glt additionally, and those in the placebo group with placebo for 6 months, respectively. the levels of serum rantes, blood glucose, blood lipids and glycosylated hemoglobin, as well as microcontent of albumin in urine were measured before and after treatment
方法在西藥降糖治療基礎上， 40例早期2型糖尿病患者，隨機分為中藥組和安慰劑組，每組20例，分別給予六味地黃軟膠囊及銀杏葉片或安慰劑治療6個月，檢測治療前後血清rantes血糖血脂糖化血紅蛋白及尿微量白蛋白水平。 -
The rate was almost nine and one - half percent in the group of women who received a placebo, an inactive pill, instead of the vitamins
而另一組服用安慰劑的孕婦孕育的低重兒的機率幾乎達到9 . 5 % ，她們是服用一種不起作用的藥片來代替維它命。 -
The researchers then studied those patients ' brain activity and bodily sensations over the course of a year, comparing what they found with the results from a group of amputees treated with a placebo
然後研究人員在一年中連續觀察這些病人的腦活動和肢體感覺，並與一組服用安慰劑的病人的檢查結果相對照。 -
The scientists said 39 percent of women in the placebo group had a pre - term delivery compared to 62 percent of women who had received metronidazole. " preterm delivery may be increased by metronidazole therapy, " shennan said in the report
研究結果顯示，在使用安慰劑的那組中，有39的孕婦最後早產然而在接受藥物甲硝唑治療的那組中，則有62的孕婦早產。 -
However, this small to medium effect became lost when placebo effect or study quality factor was considered in sub - group analysis
但是，在考慮安慰劑效應和研究質素的分組研究中，這些小至中等的療效區別不復存在。 -
In the placebo group, no significant changes of symptoms were recorded
而在安慰劑組，實驗前後沒有觀察到明顯的癥狀改善。 -
Treatment duration was a median of 23 weeks in the sorafenib group and 19 weeks in the placebo group
治療時間中位數在索拉非尼組為23周，在安慰劑組為19周。 -
Patients who supplemented with pycnogenol ? also had increased antioxidant levels compared to the placebo group
服用碧蘿芷?治療的患者的抗氧化水平也較安慰劑組有所提高。 -
In contrast to the placebo group a progressive increase of total and free tfpi was determined after the administration of the mps cream
與安慰劑組不同的是，多磺酸粘多糖乳膏組，總的和游離的組織因子旁路抑制因子（ tfpi ）水平持續增加。 -
Results showed that when patients were lying down, pycnogenol ? treatment improved capillary blood flow by 34 percent, compared to 4. 7 percent in the placebo group
實驗結果表明，當病人平躺時，碧蘿芷?組病人的的血流速度提高了37 % ，而安慰劑組僅提高了4 . 7 % 。 -
When patient ' s blood flow was measured in a standing position, pycnogenol ? treatment improved capillary blood flow by 68 percent, compared to 8 percent in the placebo group
當在病人站立狀態進行血流速度測量時，碧蘿芷?組病人毛細血管的血流速度提高了68 % ，而安慰劑組僅提高了8 % 。 -
" for every 100 patients treated with intranasal corticosteroids, seven additional patients had complete or marked symptom relief, " compared to those in the placebo group, the reviewers found
評論家比較這些研究對照組發現： 「每一百名接受鼻內皮質類固醇治療的患者中，就額外又多出七名患者的癥狀得到顯著減輕或完全緩解。 」 -
Conclusions ? bone marrow stem cell mobilization with subcutaneous g - csf is safe but did not lead to further improvement in ventricular function after acute myocardial infarction compared with the recovery observed in the placebo group. ( circulation. 2006 ; 113 : & na ; -
結論：與對照組相比，皮下注射g - csf驅動骨髓幹細胞具有安全性，但並不改善急性心肌梗死後患者的心室功能。 -
But most importantly, the plethora formulation has been shown to increase the time from penetration to ejaculation within the vagina by four times - from 0. 93 minutes in a placebo group to 3. 7 minutes with the spray - on solution
最為重要的是，該制劑業已證實可延長插入至射精時間4倍之久，安慰劑組為0 . 93分鐘，用藥組為3 . 7分鐘。
分享友人